Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABVX · against 557 other Healthcare companies listed in US-listed
Ranked #459 of 558 · scores higher than 16% of peers
Bars: peers in each 10-point band of the profitability score100 peers with a profitability score of 0–9, including ABVX · Click a bar to see the companies
Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | ABVX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -599.7% | -7.0% | 3% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -57.5% | -7.8% | 10% | 33% | |
| Return on equityHigher is better · 531 reported | -252.3% | -19.7% | 5% | Context only | |
| Gross marginHigher is better · 601 reported | 100.0% | 43.9% | 96% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 447 | 3.0B USD | 10 | 11 | |
| 447 | 504M USD | 10 | 24 | |
| 447 | 588M USD | 10 | 24 | |
| 459 | 1.3B USD | 9 | 15 | |
| 459 | 7.7B USD | 9 | 36 | |
| 459 | 37M USD | 9 | 21 | |
| 459 | 395M USD | 9 | 30 | |
| 459 | 399M USD | 9 | 32 | |
| 459 | 455M USD | 9 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score